Marker Therapeutics, Inc. TapImmune And Marker Therapeutics Announce Successful Closing Of Previously Announced Merger And Financing October 17, 2018
Read More
Read news items items specific to Ponce Therapeutics or about other Rapha Capital-related entities. Also see scientific articles detailing the rapid advances in the important science of anti-aging
News
Poseida Therapeutics Poseida Provides Update on Phase 1 Study of P-BCMA-101 CAR-T Stem Cell Memory Product in Patients with Relapsed/Refractory Multiple Myeloma Efficacy and safety continue to be a major…
Poseida Therapeutics Poseida Awarded $3.99 Million CIRM Grant to Support Preclinical Development of P-PSMA-101, a T Stem Cell Memory CAR-T Therapy for Prostate Cancer July 20, 2018
Numat Technologies NuMat Technologies Closes $12.4M Funding Round to Accelerate Commercialization of Molecularly Engineered Products April 26, 2018
Poseida Therapeutics Poseida raises $30.5 million for cancer cell therapy April 4, 2018
NexImmune Celgene vet Barer lines up a $23M startup round for next-gen I/O tech out of Johns Hopkins January 2, 2018